AR087081A1 - (1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina - Google Patents

(1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina

Info

Publication number
AR087081A1
AR087081A1 ARP120102454A ARP120102454A AR087081A1 AR 087081 A1 AR087081 A1 AR 087081A1 AR P120102454 A ARP120102454 A AR P120102454A AR P120102454 A ARP120102454 A AR P120102454A AR 087081 A1 AR087081 A1 AR 087081A1
Authority
AR
Argentina
Prior art keywords
fluoro
dimethyl
phenyl
cyclhexan
espiro
Prior art date
Application number
ARP120102454A
Other languages
English (en)
Spanish (es)
Inventor
Dr Gru Michael
Dr Kluge Stefan
Dr Prhs Stefan
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR087081A1 publication Critical patent/AR087081A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ARP120102454A 2011-07-08 2012-07-06 (1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina AR087081A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11005587 2011-07-08

Publications (1)

Publication Number Publication Date
AR087081A1 true AR087081A1 (es) 2014-02-12

Family

ID=46717800

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102454A AR087081A1 (es) 2011-07-08 2012-07-06 (1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina

Country Status (23)

Country Link
US (2) US8618156B2 (enExample)
EP (2) EP3235821B1 (enExample)
JP (2) JP6276689B2 (enExample)
CN (2) CN103649094B (enExample)
AR (1) AR087081A1 (enExample)
AU (2) AU2012283449B2 (enExample)
BR (1) BR112014000358A2 (enExample)
CA (1) CA2841032C (enExample)
CY (1) CY1120525T1 (enExample)
DK (2) DK2729470T3 (enExample)
EA (1) EA026750B1 (enExample)
ES (1) ES2641299T3 (enExample)
HR (1) HRP20170968T1 (enExample)
HU (1) HUE033043T2 (enExample)
IL (1) IL230331B (enExample)
LT (1) LT2729470T (enExample)
MX (1) MX2014000297A (enExample)
PL (1) PL2729470T3 (enExample)
PT (1) PT2729470T (enExample)
RS (1) RS56343B1 (enExample)
SI (1) SI2729470T1 (enExample)
TW (1) TWI585092B (enExample)
WO (1) WO2013007361A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2729470T3 (en) * 2011-07-08 2017-09-11 Gruenenthal Gmbh Crystalline (1r, 4r) -6'-fluoro-n, n-dimethyl-4-phenyl-4 ', 9'-dihydro-3'h-spiro [cyclohexane-1,1'-pyran [3,4, b ] indole] -4-amine
US10022353B2 (en) * 2015-01-23 2018-07-17 Grünenthal GmbH Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function
ES2713960T3 (es) 2015-02-02 2019-05-24 Ratiopharm Gmbh Composición que comprende cebranopadol en forma disuelta
JP7373904B2 (ja) 2016-02-29 2023-11-06 パーク・セラピューティクス・インコーポレイテッド セブラノパドールの滴定
CN112313202A (zh) * 2019-05-21 2021-02-02 江苏众强药业有限公司 曲前列尼尔钠盐新晶型及制备方法
CN112254496A (zh) * 2020-09-25 2021-01-22 榆林学院 一种煤泥收集装置
WO2024129782A1 (en) 2022-12-12 2024-06-20 Park Therapeutics, Inc. Regimens and compositions useful for alleviating pain
KR20250145673A (ko) 2023-02-15 2025-10-13 애드뉴리스 테라퓨틱스 인코포레이티드 통증 완화에 유용한 요법 및 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
DE102006046745A1 (de) 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
AU2011287955B2 (en) * 2010-08-04 2015-07-09 Grünenthal GmbH Pharmaceutical dosage form comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
DK2729470T3 (en) * 2011-07-08 2017-09-11 Gruenenthal Gmbh Crystalline (1r, 4r) -6'-fluoro-n, n-dimethyl-4-phenyl-4 ', 9'-dihydro-3'h-spiro [cyclohexane-1,1'-pyran [3,4, b ] indole] -4-amine

Also Published As

Publication number Publication date
BR112014000358A2 (pt) 2017-01-10
AU2012283449A1 (en) 2014-02-20
EP2729470A1 (en) 2014-05-14
WO2013007361A1 (en) 2013-01-17
EA026750B1 (ru) 2017-05-31
PT2729470T (pt) 2017-10-02
TW201311694A (zh) 2013-03-16
AU2012283449B2 (en) 2017-04-06
EP3235821B1 (en) 2020-04-08
US8765800B2 (en) 2014-07-01
CA2841032C (en) 2020-12-15
AU2017204572B2 (en) 2018-05-24
EP3235821A1 (en) 2017-10-25
IL230331B (en) 2018-11-29
RS56343B1 (sr) 2017-12-29
JP2014518226A (ja) 2014-07-28
ES2641299T3 (es) 2017-11-08
CY1120525T1 (el) 2019-07-10
JP2017081981A (ja) 2017-05-18
SI2729470T1 (sl) 2017-10-30
EP2729470B1 (en) 2017-06-21
TWI585092B (zh) 2017-06-01
DK2729470T3 (en) 2017-09-11
WO2013007361A8 (en) 2013-04-04
JP6276689B2 (ja) 2018-02-07
CN106939005A (zh) 2017-07-11
MX2014000297A (es) 2014-01-31
US20130231381A1 (en) 2013-09-05
US20130012563A1 (en) 2013-01-10
EA201400120A1 (ru) 2014-06-30
JP6559165B2 (ja) 2019-08-14
CN103649094A (zh) 2014-03-19
PL2729470T3 (pl) 2017-11-30
AU2017204572A1 (en) 2017-07-27
CN103649094B (zh) 2017-05-24
US8618156B2 (en) 2013-12-31
WO2013007361A9 (en) 2013-12-27
DK3235821T3 (da) 2020-04-20
HRP20170968T1 (hr) 2017-09-22
CA2841032A1 (en) 2013-01-17
AU2012283449A8 (en) 2014-03-27
HUE033043T2 (hu) 2017-11-28
LT2729470T (lt) 2017-08-25

Similar Documents

Publication Publication Date Title
AR087081A1 (es) (1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina
NI201400142A (es) Formas cristalinas de un modulador del receptor de androgenos
UY32809A (es) Compuestos y composiciones como inhibidores de cinasa s y k
GT201400142A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CL2013000225A1 (es) Forma de dosificacion farmaceutica que contiene 6´-fluoro-(n-metil)-o-n,n,-dimetil)-4-fenil-4´,9´-dihidro-3´-h-espiro[ciclohexan-1,1´-pirano[3,4,b])indol]-4-amina para el tratamiento de dolor neuropatico.
MX351507B (es) Composiciones farmaceuticas de co- cristales de tramadol y coxibs.
ECSP10010129A (es) Inhibidores de quinasas símil polo
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
ECSP12011720A (es) Compuestos heterocíclicos y usos de los mismos
CO6771439A2 (es) Inhibidores de benzodioxano de la producción de leucotrieno
CR20160222U (es) Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas
ECSP14026138A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
ECSP099620A (es) Derivados de ciclohexano espirociclico
CL2012000508A1 (es) Composicion para la aplicacion en cultivos agricolas al aire libre o invernaderos que comprende zeolita, y aditivos; uso de la composicion para aumentar el rendimiento de los cultivos agricolas.
CO6660435A2 (es) Una forma cristalina de clorhidrato de (r) -7- cloro-n- (quinuclidin -3-il)benzo[b] tiofeno-2- carboxamida monohodratado
CO2017000443A2 (es) Derivados de 3h, 4h, 6h, 7h-piran[3,4-d]imidazol-4-ona activos como inhibidores de la aldosterona sintasa
BR112016001876A2 (pt) composto de benzoxaborol tricíclico, método de preparação e uso do mesmo
GT201300304A (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
BR112014014202A2 (pt) formas sólidas de cloridrato de (1r,4r)-6'-fluoro-n,n-dimetil-4-fenil-4',9'-dihidro-3'h-espiro-[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina
ES2403549R1 (es) Co-cristales de agomelatina con formadores de co-cristales
AR090830A1 (es) Cocristales de metalaxil y protioconazol y procedimientos para la fabricacion y el uso de los mismos
BR112015022509A2 (pt) forma cristalina de cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina
MX2013007504A (es) Composiciones y metodos de uso de formas cristalinas de analogos de wortmanina.
AR089144A1 (es) Formas solidas de (1r,4r)-6-fluoro-(n,n-dimetil)-4-fenil-4,9-dihidro-3h-espiro-[ciclohexano-1,1-pirano-[3,4-b]indol]-4-amina y acido sulfurico
GT201500124A (es) Forma sòlida de un derivado de dihidro-pirido-oxazina

Legal Events

Date Code Title Description
FC Refusal